GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mesoblast Ltd (OTCPK:MEOBF) » Definitions » Pre-Tax Income

Mesoblast (Mesoblast) Pre-Tax Income : $-65.16 Mil (TTM As of Dec. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Mesoblast Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Mesoblast's pretax income for the three months ended in Dec. 2023 was $0.00 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was $-65.16 Mil. Mesoblast's pretax margin was %.

During the past 13 years, Mesoblast's highest Pretax Margin was -219.01%. The lowest was -4640.62%. And the median was -538.80%.


Mesoblast Pre-Tax Income Historical Data

The historical data trend for Mesoblast's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mesoblast Pre-Tax Income Chart

Mesoblast Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -98.75 -87.36 -99.63 -91.59 -82.10

Mesoblast Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -24.56 -18.65 -21.96 - -

Competitive Comparison of Mesoblast's Pre-Tax Income

For the Biotechnology subindustry, Mesoblast's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mesoblast's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mesoblast's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Mesoblast's Pre-Tax Income falls into.



Mesoblast Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Mesoblast's Pretax Income for the fiscal year that ended in Jun. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-69.289+5.801+-19.444+0.831+0
=-82.10

Mesoblast's Pretax Income for the quarter that ended in Dec. 2023 is calculated as


Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-65.16 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mesoblast  (OTCPK:MEOBF) Pre-Tax Income Explanation

Mesoblast's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin=Pretax Income/Revenue
=0/0
=%

During the past 13 years, Mesoblast's highest Pretax Margin was -219.01%. The lowest was -4640.62%. And the median was -538.80%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mesoblast Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Mesoblast's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Mesoblast (Mesoblast) Business Description

Traded in Other Exchanges
Address
Level 38, 55 Collins Street, Melbourne, VIC, AUS, 3000
Mesoblast Ltd is a clinical-stage biotechnology company. It develops and commercializes innovative allogeneic cellular medicines to treat complex diseases resistant to the conventional standard of care. Its portfolio of Phase 3 product candidates comprises remestemcel-L for the treatment of steroid-refractory acute graft versus host disease (SR-aGVHD), and for moderate to severe acute respiratory distress syndrome (ARDS) and others.